Aphena Pharma Solutions has expanded its DEA operations and storage in both its Maryland and Tennessee manufacturing locations.
Aphena’s liquid and semisolids division in Easton, Maryland, has expanded both the CII vault capacity and the DEA-licensed CIII-CV cage to hold more than 85 pallets of active products. The company has also expanded its solid-dose division in Cookeville, Tennessee, in response to the growing market demand for CII packaging. The new expansion in Tennessee will increase the location’s CII capacity to over 110 pallets for blisters, bottles, carding or kit packaging.
The Easton, Maryland, liquid and semisolid plant now includes more than 12 custom packaging lines, with additional blending equipment already on the drawing board for 2019.
Aphena's solid-dose packaging site in Cookeville, Tennessee, now has four blister lines and six bottling lines. Aphena also has four lines running pallet level serialized, with three more being installed to meet the new DSCSA regulations for pharmaceutical products in November 2018.
Customers can now work with Aphena for DEA CII-V solutions for solid dose, liquids, creams, lotions, powders, pouches, blisters, bottles, vial labeling/packaging and kitting across two divisions — the solid dose division in Tennessee and the liquids and topicals division in Maryland. This is the widest variety of packaging formats available from one single CMO source in pharma.
Aphena Pharma Solutions Inc. is an industry-leading organization providing turnkey contract packaging and manufacturing solutions for the pharmaceutical, OTC, dietary supplement, animal health, consumer health and medical device markets. With two separate FDA- and DEA-registered, GDUFA-compliant and serialization-ready sites in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspensions and lotions.